A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT02222480
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 103 participants
- Registry
-
NCT02222480
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02222480. Randomized; double masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2015-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
- Condition
- Hypertension
- Intervention (Drug)
- Fimasartan
- Intervention (Drug)
- Hydrochlorothiazide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Boryung Pharmaceutical Co., Ltd
- Collaborator
- Seoul National University Hospital
Record details
- Record id
cardio:ct-nct02222480- Content hash
8b1c4cde45534784374dfe694ee9d1a48a16760c7e3d679130bd65b27e1937b7